Hypertension, Hypertensive Disorder of Pregnancy, Postpartum
Conditions
Brief summary
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Interventions
DIAGNOSTIC_TEST2-Week Home Monitoring
Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review.
DIAGNOSTIC_TEST6-Week Home Monitoring
HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.
Sponsors
University of Minnesota
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years or older * Discharged after delivery at University of Minnesota Medical Center * Enrolled into the HOPE-BP Program
Exclusion criteria
* Ongoing antihypertensive medication use at 2 weeks (time of randomization) * Have a medical comorbidity that would not be clinically appropriate to randomize * Patients opted out of clinical research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diastolic Blood Pressure | Week 6 | The primary outcome will be the patient's diastolic blood pressure (DBP) at their 6-week postpartum visit. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 6-Week Post-partum Follow-up Rates | Week 6 | Participants who complete a 6-week post-partum visit / Total participants eligible for a 6-week post-partum visit |
| Unscheduled OB visit, triage visit, ED visit, or readmission rates | Week 6 | — |
| Systolic Blood Pressure at 6 weeks post-partum | Week 6 | Patient's systolic blood pressure at their 6-week postpartum visit |
| Rate of severe hypertension | Week 6 | defined as systolic blood pressure ≥ 160mmHg and/or DBP ≥ 110 mmHg |
| Rate of new hypertension diagnosis at 6 weeks postpartum | Week 6 | based on American Heart Association and American College of Cardiology criteria (AHA/ACC) |
| Patient Satisfaction Survey responses at 6 weeks | Week 6 | PSS Score, where higher score indicates greater satisfaction |
Countries
United States
Contacts
Primary ContactErin Linden
Outcome results
None listed